Healthstream Inc Shares Surpass Analyst Target Price of $33.33
Recently, Healthstream Inc (Symbol: HSTM) witnessed its shares trade above the average analyst 12-month target price of $33.33, reaching $33.95 per share. When a stock hits an analyst’s target, that analyst typically has two options: downgrade it based on valuation or adjust their target price upward. Their response may also depend on recent company developments contributing to the stock’s increased price. If the outlook for the company is positive, it might warrant raising the target price.
Analyst Target Insights
Three analysts within the Zacks coverage universe have contributed to Healthstream’s average target price. However, the average is simply a mathematical calculation. Notably, some analysts have lower targets, with one setting a price at $30.00, while another anticipates a high of $36.00. The standard deviation among these targets is $3.055.
The average target serves as a “wisdom of crowds” approach, amalgamating insights from different analysts rather than relying on a single perspective. With HSTM’s share price now above $33.33, investors are prompted to evaluate the company thoughtfully. They must decide whether this price signifies a step toward an even higher target or if the valuation has reached a point for potential profit-taking.
| Recent HSTM Analyst Ratings Breakdown | ||||
|---|---|---|---|---|
| » | Current | 1 Month Ago | 2 Months Ago | 3 Months Ago |
| Strong buy ratings: | 3 | 3 | 3 | 3 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 4 | 4 | 4 | 4 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 2.14 | 2.14 | 2.14 | 2.14 |
The average rating displayed above ranges from 1 to 5, where 1 is Strong Buy and 5 is Strong Sell. Data for this article is sourced from Zacks Investment Research via Quandl.com.
The views expressed herein are those of the author and do not necessarily reflect those of any other entity.
